J
Juliet N. Barker
Researcher at Memorial Sloan Kettering Cancer Center
Publications - Â 70
Citations - Â 3683
Juliet N. Barker is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Transplantation & Hematopoietic stem cell transplantation. The author has an hindex of 27, co-authored 70 publications receiving 2956 citations. Previous affiliations of Juliet N. Barker include Cornell University.
Papers
More filters
Journal ArticleDOI
The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation.
Ying Taur,Ying Taur,Robert R. Jenq,Robert R. Jenq,Miguel-Angel Perales,Miguel-Angel Perales,Eric R. Littmann,Sejal Morjaria,Lilan Ling,Daniel No,Asia Gobourne,Agnes Viale,Parastoo B. Dahi,Parastoo B. Dahi,Doris M. Ponce,Doris M. Ponce,Juliet N. Barker,Juliet N. Barker,Sergio Giralt,Sergio Giralt,Marcel R.M. van den Brink,Marcel R.M. van den Brink,Marcel R.M. van den Brink,Eric G. Pamer +23 more
TL;DR: The results indicate that the intestinal microbiota may be an important factor in the success or failure in allo-HSCT, and the diversity of the intestine microbiota at engraftment is an independent predictor of mortality in recipients.
Journal ArticleDOI
Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease
Robert R. Jenq,Robert R. Jenq,Ying Taur,Ying Taur,Sean M. Devlin,Doris M. Ponce,Doris M. Ponce,Jenna D. Goldberg,Jenna D. Goldberg,Katya F. Ahr,Eric R. Littmann,Lilan Ling,Asia Gobourne,Liza Miller,Melissa D. Docampo,Jonathan U. Peled,Jonathan U. Peled,Nicholas Arpaia,Justin R. Cross,Tatanisha Peets,Melissa Lumish,Yusuke Shono,Jarrod A Dudakov,Hendrik Poeck,Alan M. Hanash,Alan M. Hanash,Juliet N. Barker,Juliet N. Barker,Miguel-Angel Perales,Miguel-Angel Perales,Sergio Giralt,Sergio Giralt,Eric G. Pamer,Eric G. Pamer,Marcel R.M. van den Brink,Marcel R.M. van den Brink +35 more
TL;DR: It is concluded that increased abundance of commensal bacteria belonging to the Blautia genus is associated with reduced lethal GVHD and improved overall survival.
Journal ArticleDOI
Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes
Juliet N. Barker,Juliet N. Barker,Ekaterina Doubrovina,Craig S. Sauter,Jennifer Jaroscak,Miguel Perales,Miguel Perales,Mikhail Doubrovin,Susan E. Prockop,Guenther Koehne,Guenther Koehne,Richard J. O'Reilly,Richard J. O'Reilly +12 more
TL;DR: This approach demonstrates the efficacy of using "off-the-shelf," virus-specific third-party CTLs restricted by human leukocyte antigens expressed by the tumor to treat otherwise lethal EBV-PTLD.
Journal ArticleDOI
Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR
Jason Dehn,Stephen R. Spellman,Carolyn Katovich Hurley,Bronwen E. Shaw,Juliet N. Barker,Juliet N. Barker,Linda J. Burns,Linda J. Burns,Dennis L. Confer,Dennis L. Confer,Mary Eapen,Marcelo Fernandez-Vina,Robert J. Hartzman,Martin Maiers,Susana R. Marino,Carlheinz Mueller,Miguel-Angel Perales,Miguel-Angel Perales,Raja Rajalingam,Joseph Pidala +19 more
TL;DR: The National Marrow Donor Program and the Center for International Blood and Marrow Transplant Research, jointly with the NMDP Histocompatibility Advisory Group, provide evidence-based guidelines for optimal selection of unrelated donors and cord blood units.
Journal ArticleDOI
Availability of cord blood extends allogeneic hematopoietic stem cell transplant access to racial and ethnic minorities.
Juliet N. Barker,Juliet N. Barker,Courtney Byam,Nancy A. Kernan,Sinda S. Lee,Rebecca Hawke,Kathleen A. Doshi,Deborah Wells,Glenn Heller,Esperanza B. Papadopoulos,Esperanza B. Papadopoulos,Andromachi Scaradavou,James W. Young,James W. Young,Marcel R.M. van den Brink,Marcel R.M. van den Brink +15 more
TL;DR: Availability of CB significantly extends allo-transplant access, especially in non-European patients, and has the greatest potential to provide a suitable stem cell source regardless of race or ethnicity.